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Comparative Gastroscopic Study of
Choline Salicylate and Aspirin
A Preliminary Report
S. C. Danao, M.D.* and B. M. Schuman, IVLD."!'
Choline salicylate is the anhydrous
choline salt of salicylic acid. Il pos.sesses
the therapeutic effects of aspirin. Clinical trials suggest thai it is less irritating
to the gastric mucimi. A double-blind gastroscopic study of the acule effects on
the gastric muco.sa of choline .salicylate, aspirin and matching placebo was carried
out. Using the fiberoptic gastro.scope. the stomach was examined and photographed before, und ten minutes aflcr. the patient had swallowed the
tabids.
Results were evaluated on the basis of combined endo.scopic and
photographic
observations. This study suggests lhat choline .salicylate in ils tablet form causes
less gastric mucosal injury than aspirin. 'This may be due lo ils extreme
solubility, to a relatively higher pll in .solution, and lo the absence of the acetyl
radical in ils molecular .structure. Gastroscopic evaluation of acute local reaction
of ibc mucosa to drugs is belter accomplished by the combined use of ciuloscopic
and photographic
observations
and by the inclusion of a placebo in the sludy
protocol. Presence of peptic ulcer or other muco.sal abnormality
does nol ncccssarily increase the susceptibility
of the gastric mucosa lo aspirin or choline salicylate injury.

Since 1899 when pharmacologic
data about acetyl salicylic acid was
first presented by Dreser,^ aspirin has
^'een a mainstay in the physician's
therapeutic armamentarium. It soon
became evident, however, that aspirin
capable of causing gastrointestinal
Weeding.-' Attempts to overcome this
undesirable side effect led to the
appearance of various preparations in>:luding buffered, enteric-coated, and
"^ore soluble forms of aspirin.
In 1959, a new derivative of aspirin,
'Choline salicylate, was synthesized and
•Div•sion of Gastroenterology
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characterized." This is the anhydrous
choline salt of salicylic acid, with a
molecular weight of 241, of which 57"('.
is due to its salicylate content. It is the
most water-soluble of all salicylates and
because of its hygroscopic property,
it was initially available only in the
liquid form (Arlhropan"). Recently,
however, a stable tablet preparation
has been manufactured (MYBA®). A
10'.' solution of choline salicylate
gives a pH of 6.5. Pharmacologic
studies showed Ihtit choline salicylate
is non-toxic, that it is absorbed abtiul
five times more rapidly than aspirin,
lhat it maintains its plasma level as long
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as aspirin does but that peak plasma
level is attained 12 times faster than
aspirin (7.8). Clinical trials showed
that choline salicylate possesses analgesic, anti-inflammatory and antipyretic
properties equal to, if not better than,
aspirin." These studies also revealed
that gastrointestinal side effects such as
pyrosis, epigastric distress, and nausea
arc less commonly encountered in
choline salicylate compared with aspirin. Pierson and his associates, using
Cr"' tagged red blood cells, measured
the fecal blood loss after administration
of aspirin, calcium aspirin complex,
Butferin", enteric-coated aspirin and
choline salicylate. Of these preparations, only choline salicylate did not
result in gastrointestinal blood loss."
(iastroscopic observation of gastric
mucosal reaction to aspirin has been
done many times'- '' and found to be
a \aluable method for evaluating gastric
mucosal injur\'. Our purpose was to
make a double-blind comparative gastroscopic study of aspirin and the tablet
preparation of choline salicylate known
as MYBA,® with a matching placebo.
To our knowledge no similar study has
been done with choline salicylate in
any form.

bleeding; three patients had gastritis
four patients had respectively dumpies
syndrome, antral polyp, functional
vomiting and postgastrectomy state
Eighteen of the 42 patients received
aspirin, 16 received choline salicy ate
and 8 received placebo.
The patients were prepared for the
examination by intramuscular injectior.
of 50 mg of meperidine hydrochloride
and 0.4 mg of atropine sulfate given 30
to 45 minutes before the procedure
The fiberoptic gastroscope (Olympu
Model GTF-A) was used to surve\ th
stomach, with 12 to 15 pictures take
of the antrum, body of the stomach
and the fundus at the area of the mucii
pool. Endoscopic observations were
made and recorded by at leasl tw
endoscopists. After the instrumenl wa
removed, the patient swallowed three
tablets with water ad lib. All tablet
were identical in appearance and th
constituents unknown to the endo
scopist. The pharyngeal mucosa wuswabbed with 5^ hexylcaine. Ten minutes after the tablets were swalKnve.
the fiberoptic gastroscope was re-inlrcduced. The stomach was surveyed and
pertinent areas rephotographed. Pitures were taken of the disintegrate:
tablets at various areas of the stomarf
Endoscopic observations were recorded. The gastrocamera films spread independently by the two endoscopists two to three days later. Tfc;
degree of severity of mucosal reactio'
was graded according to the followi'.scale: 1 point for erythema; 2 poi"for hemorrhage; 2 points for petechiaand 2 points for erosion. This ratir^
scale was used for both the endoscopand photographic observations. Af"^
completing the tabulation of the resu'for each of the 30 patients, the coc

Materials and Methods
Forty-two patients from both the
inpatient service and outpatient clinic
were included in the study. There were
18 female and 24 male patients with
ages ranging from 32 to 76. Seventeen
patients had proven or suspected gastric ulcers; four patients had proven or
suspected duodenal ulcers; six patients
had complaints attributed to functional
gastrointestinal disturbances; two palienis had gastric cancer; six patients
had unexplained upper gastrointestinal
28
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dences of mucosal injury. The remaining six patients showed mucosal
reaction during gastroscopy but photographic evidence was normal.
Eighteen patients received aspirin.
Nine showed a positive reaction. Of
these nine who reacted, six had normal
gastric mucosa, one had a gastric ulcer,
one had an antral polyp and one had
antral gastritis. Of the nine patients
who did not react to aspirin, two had
duodenal ulcer, four had gastric ulcer,
one had gastritis, and two had normal
mucosa.
Sixteen patients received choline
salicylate. Seven showed a positive
leaction. Of these seven, one had gastric carcinoma, two had gastric ulcer,
one had gastritis while the other three
showed normal mucosa. Of the nine
patients who did not react to choline
salicylate, two had duodenal ulcer,
three had gastric ulcer, one had gastric
carcinoma, one had mucosal telangiectasia and two had normal mucosa
Six patienis in the study had upper
gastrointestinal bleeding of undeiLimined etiology. One had a positive
reaction wilh the placebo. Three patients received aspirin with one showing
a positive reaction. The other two
patients received choline salicylate with
one showing a positive mucosal reaction.
Fifteen patients of the entire group
were past users of aspirin. Eight
patients were using aspirin regularly,
taking several tablets almost daily
while seven patients used it occasionally. Among the eight regular users,
three received aspirin with one showing
positive reaction, two received choline
salicylate to which one showed a
reaction, and the other three received
placebo tablets with no reaction.

was broken and the tablets given each
patient identified.
Results
Of the 42 examinations, 22 showed
no gastroscopic evidence of gastric
mucosal injury. Of these 22 negative
cases, 4 occurred in the placebo group,
9 in the aspirin group, and 9 in the
MYBA group. The other 20 showed
ng degrees of mucosal injun,. Of
these 20 positive cases, 9 occurred in
the aspirin group. 7 in the MYBA
group, and 4 in the placebo group.
Therefore, 50".'i of the aspirin cases
were positive, 50^1 of the placebo
cases were positive, and 43.8% of the
\lVB-\ cases were positive. Using our
rating scale, the nine positive aspirin
cases had 23 points, the seven positive
MYBA cases had 16 points, and the
four positive placebo cases had 18
points These points represent the total
of both endoscopic and photographic
observations for each individual case.
Particles of the tablets in varying
degrees of disintegration were consistently demonstrated in the antrum,
body, or the mucus pool of the fundus.
The most common reaction was erythema localized around the tablet particles, noted in 15 patients. Diffuse
erythema was seen in only one case.
^ hemorrhagic reaction was noted in
eight patients, with free blood in the
gastric lumen seen in three cases. Two
patients exhibited petechiae and one
showed erosions at the vicinity of the
dissolved tablets.
Of the 20 positive cases, 8 patients
showed mucosal reaction in both gas'roscopic and photographic observa''°ns. Six patients did not show mucosal
^^action during gastroscopy, but reof the photographs revealed evi29
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Of the nine patients who showed
reaction to aspirin, four gave a history
of aspirin intake. Among the nine
patients who did not show reaction to
aspirin, only two had used aspirin
previously. Of the seven patients who
showed reaction to choline salicylate,
two had a history of aspirin intake.
Among the nine patients who did not
react to choline salicylate, two had a
history of aspirin intake.

duced injury in the gastric mucosa has
been reviewed recently.'^-^^ While the
exact mechanism has not been elaborated, several factors have been incriminated.
Davenport-" felt that the absorption
of aspirin causes damage to the gastric
mucosal barrier allowing back diffusion
of hydrogen ions which induces bleeding. At pH 2.5. aspirin exists in the
un-ionized, lipid-soluble form which
is more rapidly absorbed through the
lipoprotein membrane of the gastric
mucosal cells. At pH 6.5, aspirin becomes poorly absorbed by the gastric
mucosa. The importance of intragastric
pH in the production of bleeding by
aspirin has been well documented in
both animal experiments-*--- and in
experiments with volunteers.'" Choline
salicylate in solution has a pH of about
6.5.
Another important factor is the
dissolution rate of the salicylate preparation.-' There appears to be an inverse correlation between solubilit}
and amount of blood loss as measured
in the feces. Calcium-aspirin complex,
which is more soluble than aspirin,
caused a smaller amount of blood loss
compared to aspirin." In this respect,
choline salicylate is the most soluble
of all salicylate preparations.
Another interesting obser\'ation is
the absence of gastrointestinal bleeding
when enteric-coated sodium salicylate
was given.-'
This is probably unrelated to the coating of the tablet
since both uncoated and enteric-coated
aspirin produced significant bleedingOn the other hand, sodium salicylate
and choline salicylate have one common characteristic in their chemical
structure which is not found in aspin"
the absence of the acetyl radical. The

Comment
Analysis of the raw data suggests
lhal choline salicylate causes less mucosal injury than aspirin. Because
analysis of the present study does not
yield statistically significant differences
between the experimental groups, further sludies are in order. We believe
these additional studies tire likely to
sharpen ihe differences already observed in the experimental groups.
This study suggests that choline
salicylate in its tablet form causes less
gastric mucosal injury Ihan aspirin.
Previous sludies comparing these two
forms of salicylates agree. Clinical
trials using the liquid form of choline
salicylate have shown lhal il is belter
tolerated and causes less gastrointestinal side effects than aspirin.""* This
was especially true when larger doses
of salicylates were adniinislered. It
was also noted lhat most patients who
developed epigastric distress with aspirin loleraleJ comparable doses ot
choline salicylate very well. Measurements of fecal blood loss, using Cr-''tagged red blimd cells, revealed that
of six salicylate preparations used, only
choline salicylate did not result in
ga.strointcstinal blcH>d loss."
The pathogenesis of the aspirin-in30
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possibility is raised therefore that the
presence of the acetyl radical in the
molecule of aspirin may be a factor in
causing gastric mucosal injury."
This study utilizes both endoscopic
and photographic observations in
evaluating gastric mucosal injury. Similar -tudies with aspirin had employed
either purely gastroscopic observation
' or blind intragastric photographs ' Our findings show that mucosal
reaction varying from erythema to
hemorrhagic changes can be missed if
nil\ one procedure is used. Vigorous
[\iMalsis and the effect of antral spasm
and retained secretions occasionally
may .ifford only fleeting views of some
.irc.i^ of the stomach, thus hampering
mucosal evaluation by even the expciiciiced endoscopist. This disadvans obviated by a detailed leisurely
review of photographs taken during
the endoscopy. On the other hand,
blind intragastric photography cannot
always be a subslitute for gastroscopy.
This has been pointed out by Schindler"' and Nelson.-" It is our impression
thai gastroscopy and gastropholography
complement each other and that the
optimum result is obtained when both
procedures are used.
An unexpected finding is the positive
reaction of four patients who received
placebo tablets. All four showed mucosal hemorrhagic changes. The place-

bo tablets (composed of Lactose) contain no constituent known to cause
gastric mucosal injury. It is possible
that a pre-existing gastric lesion may result in an altered mucosal reactivity so
that even inert substances may provoke
mucosal change. Three patients had no
demonstrable gastric pathology while
the fourth had a gastric ulcer which
was completely healed al the linu- ol
the study. Another important consideration is the emotional state of the
patient during the time of examination.
It has been demonstrated that nuKosal
changes varying from erythema to
hemorrhage c;in be provoked by emotional upset.'-"' These four patients,
however, did not show any unusual
reaction lo the examinations we performed. While we have no definite
explanation for these placebo reactors,
our findings emphasize the imporlance
of including a placebo in the protocol
of any similar study.
Weiss' gastroscopic sludy of aspirin
and gastric bleeding led him to conclude that persons wilh peptic iilcer
and abnormal mucosa are more susceptible lo mucosal injury by aspirin.'^
Our data suggests that susceptibility of
the gastric mucosa to injury by aspirin
and choline salicylate is not necessarily
increased by the presence of pre-existing peptic ulcer or other mucosal abnormality.
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